Expertise in
18
conditions

Yong-jin W. Kim

Seoul, KR 
Expertise in
18
conditions
Seoul, KR 

Overview

Yong-jin Kim practices practicing medicine in Seoul, Republic of Korea.

Kim is highly rated in 18 conditions, according to our data. Their clinical expertise encompasses Hypertrophic Cardiomyopathy (HCM), Coronary Heart Disease, Cardiomyopathy, Sleeve Gastrectomy, and Gastric Bypass.

They are actively involved in clinical research, co-authoring 558 peer reviewed articles and participating in 3 clinical trials.

Locations

Seoul, Republic of Korea
Other Locations
Daegu, Republic of Korea
Daejeon, Republic of Korea
Yuseong, Republic of Korea
R&D Unit, Yongin, Republic of Korea
Gyeonggi-do, Republic of Korea
Ulsan, Republic of Korea
Yangsan, Republic of Korea
Jeonju, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Multicenter, Randomized, 2 x 2 Factorial, Phase 3 Study to Assess the Efficacy of Carvedilol and Empagliflozin on Improvement of Right Ventricular Remodeling in Patients With Severe Functional Tricuspid Regurgitation
Multicenter, Randomized, 2 x 2 Factorial, Phase 3 Study to Assess the Efficacy of Carvedilol and Empagliflozin on Improvement of Right Ventricular Remodeling in Patients With Severe Functional Tricuspid Regurgitation
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Drug
Study Drugs: Carvedilol+Empagliflozin, Carvedilol, Empagliflozin
Study Phase: Phase 3
Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Assess the Efficacy of Ertugliflozin on Reduction of Mitral Regurgitation in Patients With Functional Mitral Regurgitation Secondary to Left Ventricular Dysfunction
Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Assess the Efficacy of Ertugliflozin on Reduction of Mitral Regurgitation in Patients With Functional Mitral Regurgitation Secondary to Left Ventricular Dysfunction
Enrollment Status: Completed
Publish Date: January 06, 2025
Intervention Type: Drug
Study Drug: Ertugliflozin
Study Phase: Phase 3
A Multicenter, Double-blind, Placebo-controlled, Stratified-randomized, Parallel, Therapeutic Exploratory Clinical Study to Evaluate the Efficacy and Safety of DA-1229 in Patients With Calcific Aortic Valve Disease
A Multicenter, Double-blind, Placebo-controlled, Stratified-randomized, Parallel, Therapeutic Exploratory Clinical Study to Evaluate the Efficacy and Safety of DA-1229 in Patients With Calcific Aortic Valve Disease
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug
Study Drug: DA-1229
Study Phase: Phase 2
View 2 Less Clinical Trials

551 Total Publications

Association of Low-Attenuation Noncalcified Plaque Shape and Degree of Intraplaque Embeddedness Using Atherosclerotic Imaging-enabled Quantitative CT with Acute Coronary Syndrome.
Association of Low-Attenuation Noncalcified Plaque Shape and Degree of Intraplaque Embeddedness Using Atherosclerotic Imaging-enabled Quantitative CT with Acute Coronary Syndrome.
Journal: Radiology. Cardiothoracic imaging
Published: July 23, 2026

Frequently Asked Questions about Yong-jin W. Kim

Is Yong-jin W. Kim a top-rated expert for Hypertrophic Cardiomyopathy (HCM)?

MediFind is an objective health platform that identifies experts based on real-world data. Yong-jin W. Kim is classified as an Distinguished expert for Hypertrophic Cardiomyopathy (HCM), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yong-jin W. Kim participate in research or clinical trials?

Yes. Yong-jin W. Kim has published 551 articles and abstracts on conditions like Hypertrophic Cardiomyopathy (HCM). You can view a list of Yong-jin W. Kim's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kim's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 67 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile